draft manuscript: YB, MS, and SS
Participants will be part of a 4-week in-patient program
This counterintuitive finding, where a lower dose shows higher risk than a higher dose, suggests that the relationship between tirzepatide and gallbladder problems may not be purely dose-dependent
But by March 12, some Hers users were receiving a different message: Their subscriptions will be canceled, with a refund, in May because they have been taking a commercially available dose
For most patients starting Zepbound, healthcare providers typically recommend obtaining a baseline lipid panel and repeating the assessment after 3-6 months of treatment
This leads to increased fullness, reduced appetite, and significant weight loss